Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
1 Year
—
-13.91%
Shrank
—
—
Grew
—
1 Year
Score—
Net Growth-13.91%
Net TrendShrank
Net Income Consistency—
Rev Growth—
Rev TrendGrew
Revenue Consistency—
5 Years
—
44.72%
60%
—
—
20%
—
5 Years
Score—
Net Growth44.72%
Net Trend60%
Net Income Consistency—
Rev Growth—
Rev Trend20%
Revenue Consistency—
NRX Pharmaceuticals Inc fundamental performance
Across NRX Pharmaceuticals Inc's full reported history, from 2017 to 2025, net income went from -$ 105K to -$ 28M. Revenue increased in 20% of the years measured; net income in 63%.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 3.36 | — |
1 Year2025-08-12 | $ 2.39 | 40.59% |
5 Years2021-08-12 | $ 154.10 | -97.82% |
All Time2017-12-04 | $ 96.00 | -96.50% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | All Time2017-12-04 |
|---|---|---|---|---|
| Price | $ 3.36 | $ 2.39 | $ 154.10 | $ 96.00 |
| Return | — | 40.59% | -97.82% | -96.50% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2025 | $ 1M | -$ 28M | $ 7M |
| 2024 | $ 0.00 | -$ 25M | $ 1M |
| 2023 | $ 0.00 | -$ 30M | $ 4M |
| 2022 | $ 0.00 | -$ 39M | $ 20M |
| 2021 | $ 0.00 | -$ 93M | $ 27M |
| 2020 | $ 0.00 | -$ 51M | $ 1M |
| 2019 | $ 408.43K | $ 6.00 | |
| 2018 | $ 66.1K | $ 11.08K | |
| IPO2017 | -$ 105K | $ 449.37K |
Explore beyond NRXP
You're looking at NRX Pharmaceuticals Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
